Latest On Reata Pharmaceuticals, Inc (RETA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-24 21:07 EST | News | Reata adds 21% as PTC’s Friedreich's ataxia drug fails Phase 3 trial | N/A |  |
| 2023-05-23 16:54 EST | News | Reata Pharmaceuticals: 'Buy' Following Skyclarys Delay And Bardoxolone Discontinuation (Rating Upgrade) | N/A | |
| 2023-05-11 09:45 EST | News | Reata Pharmaceuticals, Inc. (RETA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-10 19:51 EST | News | Reata Pharmaceuticals Non-GAAP EPS of -$1.81 in-line, revenue of $0.2M beats by $0.04M | N/A | |
| 2023-05-10 19:51 EST | News | Reata sheds 18% after halting kidney disease programs | N/A | |
| 2023-05-10 19:51 EST | News | Reata Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-09 17:33 EST | News | Reata Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-29 11:14 EST | News | Reata Pharmaceuticals: Still A Buy After Skyclarys Approval Jump | N/A | |
| 2023-03-23 23:44 EST | News | Skyclarys' Positive Reception By FDA And Medical Community Bolsters Reata's Future | N/A | |
| 2023-03-06 18:25 EST | News | Reata Pharmaceuticals: The Silver Bullet For Friedreich's Ataxia | N/A | |
| 2023-03-01 15:34 EST | News | Reata surges 183% on Friedreich's ataxia drug approval; Skyclarys peak sales could top $1B | N/A | |
| 2023-03-01 15:34 EST | News | Reata adds 190% to reach two year-high after FDA nod for rare disease therapy | N/A | |
| 2023-03-01 00:33 EST | News | Reata Pharmaceuticals up 192% on Friedreich's ataxia drug omaveloxolone approval | N/A | |
| 2023-02-27 18:58 EST | News | Reata in selloff ahead of FDA decision on lead asset as top agency official departs (Update) | N/A | |
| 2023-02-17 20:38 EST | News | Reata adds 14% ahead of FDA decision on Friedreich’s ataxia therapy | N/A | |
| 2023-02-17 07:00 EST | News | Reata Pharmaceuticals' Omaveloxolone CRL Appears Imminent | N/A | |
| 2023-01-22 19:59 EST | News | Reata Pharmaceuticals: Binary Catalyst Unlocking | N/A | |
| 2023-01-04 09:30 EST | News | Reata Pharmaceuticals: Buy While Preparing For First Commercial Launch | N/A | |
| 2022-11-08 18:04 EST | News | Reata Pharmaceuticals Non-GAAP EPS of -$1.47 beats by $0.58, revenue of $0.54M misses by $0.19M | N/A | |
| 2022-11-08 18:04 EST | News | Reata rises 15% as omaveloxolone moves ahead in FDA review process; plans EU filing | N/A | |
| 2022-11-08 18:03 EST | News | Reata Pharmaceuticals, Inc. (RETA) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-07 23:50 EST | News | Reata Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-10-19 13:23 EST | News | Why Reata Pharmaceuticals Could Perform Below Expectations | N/A | |
| 2022-10-14 06:46 EST | News | FDA to not hold advisory committee meeting for Reata Pharma's Friedreich's ataxia drug | N/A | |
| 2022-09-07 23:44 EST | News | Amylyx drives Reata, Ardelyx higher ahead of FDA AdCom decision on ALS drug | N/A | |
| 2022-08-10 04:51 EST | News | Reata stock slips as FDA extends review period for rare disorder drug omaveloxolone | N/A | |
| 2022-08-09 07:04 EST | News | Reata Pharmaceuticals Non-GAAP EPS of -$1.36 beats by $0.61, revenue of $0.76M misses by $0.7M | N/A | |
| 2022-08-09 07:04 EST | News | Reata Pharma falls 22% on Q2 revenue miss | N/A | |
| 2022-08-09 07:04 EST | News | Reata Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-09 07:04 EST | News | Reata Pharmaceuticals, Inc.'s (RETA) CEO Warren Huff on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 07:03 EST | News | Reata drops 33%, most since December; Goldman sees favorable risk reward profile | N/A | |
| 2022-08-05 22:55 EST | News | Reata Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-05-28 01:15 EST | News | Reata extends gains as Citi welcomes regulatory win for lead asset | N/A | |
| 2022-05-26 16:59 EST | News | Reata's omaveloxolone gets FDA priority review for rare neuromuscular disorder | N/A | |
| 2022-05-11 08:28 EST | News | Reata Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-11 08:28 EST | News | Reata Pharmaceuticals' (RETA) CEO Warren Huff on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 12:40 EST | News | Reata Pharmaceuticals Non-GAAP EPS of -$1.33 beats by $0.63, revenue of $0.91M misses by $0.64M | N/A | |
| 2022-05-10 12:39 EST | News | Reata Pharma surges as Goldman sets a Street high target | N/A | |
| 2022-05-09 15:41 EST | News | Reata Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-03-29 09:08 EST | News | Reata Pharmaceuticals down 31% as a consequence of FDA docs on Amylyx ALS candidate | N/A | |
| 2022-03-29 09:07 EST | News | Reata defended at Citi after FDA comments on ALS drug | N/A | |
| 2022-03-29 09:07 EST | News | Reata Pharmaceuticals: Once Beaten, Twice Shy | N/A | |
| 2022-03-24 21:59 EST | News | Reata draws Buy rating at Goldman on potential for neuromuscular disease therapy | N/A | |
| 2022-02-28 17:40 EST | News | Reata Pharmaceuticals Non-GAAP EPS of -$1.59 beats by $0.34, revenue of $0.93M misses by $0.83M | N/A | |
| 2022-02-28 17:40 EST | News | Reata Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-28 17:40 EST | News | Reata Pharmaceuticals down 5% on FDA rejection, revenue miss | N/A | |
| 2022-02-28 17:40 EST | News | Reata Pharmaceuticals Inc.'s (RETA) CEO Warren Huff on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-26 08:04 EST | News | Reata slips as FDA rejects kidney disease therapy | N/A | |
| 2022-01-31 21:56 EST | News | Reata initiates rolling submission of omaveloxolone application in U.S. for Friedreich’s ataxia | N/A | |
| 2022-01-04 17:26 EST | News | Reata Pharma gains on first insider transaction since June 2021 | N/A | |
About Reata Pharmaceuticals, Inc (RETA):
Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone that is Phase II clinical trial to treat Friedreich's ataxia; and conduct Phase II study for various form of CKD, such as IgA nephropathy, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and RTA 1701 for the potential treatment of a range of autoimmune, inflammatory, and fibrotic diseases. In addition, the company offers bardoxolone for the treatment of autosomal dominant polycystic kidney disease. Further, it has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; and AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.
General
- Name Reata Pharmaceuticals, Inc
- Symbol RETA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 261
- Fiscal Year EndDecember
- IPO Date2016-05-26
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.reatapharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 485.33
- Price/Book (Most Recent Quarter) 11.26
- Enterprise Value Revenue 430.48
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$9.89
- Next Year EPS Estimate -$6.39
- Next Quarter EPS Estimate -$2.17
- Operating Margin -2509%
- Return on Assets -18%
- Return on Equity -73%
- Revenue 9.02 million
- Earnings Per Share -$4.06
- Revenue Per Share $0.27
- Gross Profit -150061000
- Quarterly Earnings Growth 19.5%
View More
Highlights
- Market Capitalization 4.26 billion
- EBITDA -116066000
- PE Ratio -15.52
- Analyst Target Price $243.38
- Book Value Per Share $11.55
View More
Share Statistics
- Shares Outstanding 31.29 million
- Shares Float 29.87 million
- % Held by Insiders 477%
- % Held by Institutions 71.49%
- Shares Short 3.31 million
- Shares Short Prior Month 3.29 million
- Short Ratio 12.31
- Short % of Float 14%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 1.62
- 52 Week High $186.82
- 52 Week Low $88.17
- 50 Day Moving Average 120.08
- 200 Day Moving Average 122.14
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Reata Pharmaceuticals, Inc (RETA) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Reata Pharmaceuticals, Inc (RETA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $3.19 million | -$1.90 | -$2.16 | 11.87% |
| 2020-09-30 | 2020-11-09 | $N/A | -$1.94 | -$2.04 | 5.09% |
| 2020-06-30 | 2020-08-10 | $N/A | -$2.03 | -$2.92 | 30.36% |
| 2020-03-31 | 2020-05-11 | $1.35 million | -$1.47 | -$1.99 | 25.97% |
| 2019-12-31 | 2020-02-19 | $2.67 million | -$5.91 | -$5.15 | -14.73% |
| 2019-09-30 | 2019-11-12 | $8.24 million | -$1.32 | -$1.24 | -6.31% |
| 2019-06-30 | 2019-08-08 | $7.81 million | -$1.14 | -$1.12 | -1.49% |
| 2019-03-31 | 2019-05-09 | $7.73 million | -$0.98 | -$1.00 | 1.74% |
| 2018-12-31 | 2019-02-28 | $7.9 million | -$0.86 | -$1.07 | 19.87% |
| 2018-09-30 | 2018-11-07 | $4.77 million | -$1.07 | -$0.79 | -35.39% |
| 2018-06-30 | 2018-08-08 | $7.52 million | -$1.08 | -$0.73 | -47.99% |
| 2018-03-31 | 2018-05-08 | $32.17 million | $0.15 | -$0.61 | 124.43% |
| 2017-12-31 | 2018-03-02 | $9.96 million | -$0.64 | -$0.56 | -13.7% |
| 2017-09-30 | 2017-11-13 | $12.56 million | -$0.50 | -$0.38 | -30.58% |
| 2017-06-30 | 2017-08-14 | $12.81 million | -$0.52 | -$0.28 | -83.1% |
| 2017-03-31 | 2017-05-10 | $12.73 million | -$0.32 | -$0.12 | -166.67% |
| 2016-12-31 | 2017-03-03 | $12.5 million | -$0.19 | -$0.13 | -42.22% |
| 2016-09-30 | 2016-11-14 | $12.55 million | -$0.04 | -$0.14 | 71.18% |
| 2016-06-30 | 2016-08-11 | $12.37 million | -$0.05 | -$0.10 | 48.67% |
| 2016-03-31 | 2016-05-16 | $12.44 million | -$0.01 | -$0.22 | 94.73% |
Reata Pharmaceuticals, Inc (RETA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Reata Pharmaceuticals, Inc (RETA) Chart:
Reata Pharmaceuticals, Inc (RETA) News:
Below you will find a list of latest news for Reata Pharmaceuticals, Inc (RETA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Reata Pharmaceuticals, Inc (RETA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | 90 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 95 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 100 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 105 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 110 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 115 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 120 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 125 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 130 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 135 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 140 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 145 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 150 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 155 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 160 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 165 | 10.5 | CALL | 0 | 9 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 170 | 3 | CALL | 0 | 5 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 175 | 0.1 | CALL | 0 | 90 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 180 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 185 | 0.15 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 190 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 195 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 200 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 210 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 220 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 230 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 240 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 250 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 90 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 95 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 100 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 105 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 110 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 115 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 120 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 125 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 130 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 135 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 140 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 145 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 150 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 155 | 0.4 | PUT | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 160 | 0.65 | PUT | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 165 | 0.25 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 170 | 0.05 | PUT | 0 | 128 | 2.58 | FALSE | 0 | 0 |
| 2026-01-16 | 175 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 180 | 0 | PUT | 0 | 0 | 11.42 | TRUE | 0 | 0 |
| 2026-01-16 | 185 | 0 | PUT | 0 | 0 | 13.81 | TRUE | 0 | 0 |
| 2026-01-16 | 190 | 0 | PUT | 0 | 0 | 15.89 | TRUE | 0 | 0 |
| 2026-01-16 | 195 | 0 | PUT | 0 | 0 | 17.78 | TRUE | 0 | 0 |
| 2026-01-16 | 200 | 0 | PUT | 0 | 0 | 19.53 | TRUE | 0 | 0 |
| 2026-01-16 | 210 | 0 | PUT | 0 | 0 | 22.71 | TRUE | 0 | 0 |
| 2026-01-16 | 220 | 0 | PUT | 0 | 0 | 25.58 | TRUE | 0 | 0 |
| 2026-01-16 | 230 | 0 | PUT | 0 | 0 | 28.22 | TRUE | 0 | 0 |
| 2026-01-16 | 240 | 0 | PUT | 0 | 0 | 30.66 | TRUE | 0 | 0 |
| 2026-01-16 | 250 | 0 | PUT | 0 | 0 | 32.96 | TRUE | 0 | 0 |
Latest RETA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 67 | $30.97 |
| Jun 13, 2022 7:59 PM EST | 25 | $30.965 |
| Jun 13, 2022 7:59 PM EST | 100 | $30.965 |
| Jun 13, 2022 7:59 PM EST | 1 | $31.01 |
| Jun 13, 2022 7:59 PM EST | 13 | $30.985 |
Reata Pharmaceuticals, Inc (RETA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1358762/000135876220000001/0001358762-20-000001-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000021545719005813/0000215457-19-005813-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000083423720006678/0000834237-20-006678-index.htm |
| 2020-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000083423720010344/0000834237-20-010344-index.htm |
| 2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924318028919/0000899243-18-028919-index.htm |
| 2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924318028928/0000899243-18-028928-index.htm |
| 2018-11-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924318028932/0000899243-18-028932-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924319016986/0000899243-19-016986-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000089924320017404/0000899243-20-017404-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000090221920000207/0000902219-20-000207-index.htm |
| 2020-04-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000090221920000376/0000902219-20-000376-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819000643/0000905148-19-000643-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/0000905148-19-001001-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001002/0000905148-19-001002-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001003/0000905148-19-001003-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001034/0000905148-19-001034-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001035/0000905148-19-001035-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514820000001/0000905148-20-000001-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000090514820000715/0000905148-20-000715-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000093247119005788/0000932471-19-005788-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358762/000110465920018376/0001104659-20-018376-index.htm |
| 2018-11-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1358762/000119312518326710/0001193125-18-326710-index.htm |
| 2019-11-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1358762/000119312519290110/0001193125-19-290110-index.htm |
| 2019-11-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1358762/000119312519292390/0001193125-19-292390-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000119312519292453/0001193125-19-292453-index.htm |
| 2019-11-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1358762/000119312519296316/0001193125-19-296316-index.htm |
| 2018-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/0001209191-18-056805-index.htm |
| 2018-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/0001209191-18-057707-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919118059094/0001209191-18-059094-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919118063808/0001209191-18-063808-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000757/0001209191-19-000757-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000768/0001209191-19-000768-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000770/0001209191-19-000770-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000781/0001209191-19-000781-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000786/0001209191-19-000786-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/0001209191-19-000798-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000807/0001209191-19-000807-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000813/0001209191-19-000813-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003067/0001209191-19-003067-index.htm |
| 2019-01-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003397/0001209191-19-003397-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003672/0001209191-19-003672-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003934/0001209191-19-003934-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119005738/0001209191-19-005738-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/0001209191-19-006341-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006736/0001209191-19-006736-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119007666/0001209191-19-007666-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119010954/0001209191-19-010954-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/0001209191-19-014057-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017820/0001209191-19-017820-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017824/0001209191-19-017824-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020406/0001209191-19-020406-index.htm |
| 2019-03-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020743/0001209191-19-020743-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024119/0001209191-19-024119-index.htm |
| 2019-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024731/0001209191-19-024731-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119030723/0001209191-19-030723-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119034656/0001209191-19-034656-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119036719/0001209191-19-036719-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119036730/0001209191-19-036730-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119036757/0001209191-19-036757-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119037987/0001209191-19-037987-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119042341/0001209191-19-042341-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119046280/0001209191-19-046280-index.htm |
| 2019-08-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119047697/0001209191-19-047697-index.htm |
| 2019-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119047700/0001209191-19-047700-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119049007/0001209191-19-049007-index.htm |
| 2019-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119049420/0001209191-19-049420-index.htm |
| 2019-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119050613/0001209191-19-050613-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119051083/0001209191-19-051083-index.htm |
| 2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053054/0001209191-19-053054-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053131/0001209191-19-053131-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053134/0001209191-19-053134-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053437/0001209191-19-053437-index.htm |
| 2019-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053681/0001209191-19-053681-index.htm |
| 2019-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053686/0001209191-19-053686-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119054248/0001209191-19-054248-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119054468/0001209191-19-054468-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119056100/0001209191-19-056100-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119056108/0001209191-19-056108-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119056119/0001209191-19-056119-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119056130/0001209191-19-056130-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119056140/0001209191-19-056140-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119058681/0001209191-19-058681-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060920/0001209191-19-060920-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001618/0001209191-20-001618-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001623/0001209191-20-001623-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001629/0001209191-20-001629-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001632/0001209191-20-001632-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001636/0001209191-20-001636-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001639/0001209191-20-001639-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120001647/0001209191-20-001647-index.htm |
| 2020-01-09 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120002828/0001209191-20-002828-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120014386/0001209191-20-014386-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120033270/0001209191-20-033270-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120038169/0001209191-20-038169-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120038198/0001209191-20-038198-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120038207/0001209191-20-038207-index.htm |
| 2020-08-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120044694/0001209191-20-044694-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120044706/0001209191-20-044706-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358762/000120919120046765/0001209191-20-046765-index.htm |
| 2020-06-25 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1358762/000135876220000001/0001358762-20-000001-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459018027704/0001564590-18-027704-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459018027708/0001564590-18-027708-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019005158/0001564590-19-005158-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1358762/000156459019005161/0001564590-19-005161-index.htm |
| 2019-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358762/000156459019005461/0001564590-19-005461-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1358762/000156459019013939/0001564590-19-013939-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1358762/000156459019013962/0001564590-19-013962-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019017549/0001564590-19-017549-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459019017552/0001564590-19-017552-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019022456/0001564590-19-022456-index.htm |
| 2019-06-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358762/000156459019022474/0001564590-19-022474-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019030387/0001564590-19-030387-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459019030393/0001564590-19-030393-index.htm |
| 2019-08-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019032828/0001564590-19-032828-index.htm |
| 2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019033368/0001564590-19-033368-index.htm |
| 2019-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019036739/0001564590-19-036739-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019036894/0001564590-19-036894-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019037025/0001564590-19-037025-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019042509/0001564590-19-042509-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459019042512/0001564590-19-042512-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459019046546/0001564590-19-046546-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020005271/0001564590-20-005271-index.htm |
| 2020-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1358762/000156459020005272/0001564590-20-005272-index.htm |
| 2020-02-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358762/000156459020006775/0001564590-20-006775-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1358762/000156459020019387/0001564590-20-019387-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1358762/000156459020019395/0001564590-20-019395-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020024170/0001564590-20-024170-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459020024185/0001564590-20-024185-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020028059/0001564590-20-028059-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020028944/0001564590-20-028944-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020029006/0001564590-20-029006-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020030358/0001564590-20-030358-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020031880/0001564590-20-031880-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020034969/0001564590-20-034969-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020038578/0001564590-20-038578-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358762/000156459020038583/0001564590-20-038583-index.htm |
| 2020-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358762/000156459020041439/0001564590-20-041439-index.htm |
| 2020-02-05 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1358762/999999999720000515/9999999997-20-000515-index.htm |
| 2020-02-18 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1358762/999999999720000735/9999999997-20-000735-index.htm |
Reata Pharmaceuticals, Inc (RETA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reata Pharmaceuticals, Inc (RETA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 477%Institutional Ownership: 7149%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-01-07 | Jason Douglas Wilson | Chief Financial Officer | Sell | 20,000.00 | 72.04 | 1,440,820.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003067/0001209191-19-003067-index.htm |
| 2019-01-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,272.00 | 71.59 | 91,065.41 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003934/0001209191-19-003934-index.htm |
| 2019-01-31 | Jason Douglas Wilson | Chief Financial Officer | Sell | 6,135.00 | 80.00 | 490,800.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006736/0001209191-19-006736-index.htm |
| 2019-02-01 | Jason Douglas Wilson | Chief Financial Officer | Sell | 865.00 | 80.00 | 69,200.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006736/0001209191-19-006736-index.htm |
| 2019-02-05 | Jason Douglas Wilson | Chief Financial Officer | Sell | 3,000.00 | 80.00 | 240,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119007666/0001209191-19-007666-index.htm |
| 2019-02-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 4,000.00 | 85.44 | 341,760.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119010954/0001209191-19-010954-index.htm |
| 2019-03-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 4,000.00 | 93.62 | 374,469.60 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020406/0001209191-19-020406-index.htm |
| 2019-03-18 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,604.00 | 95.11 | 152,556.44 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020406/0001209191-19-020406-index.htm |
| 2019-03-19 | Jason Douglas Wilson | Chief Financial Officer | Sell | 100.00 | 95.69 | 9,569.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020743/0001209191-19-020743-index.htm |
| 2019-04-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 293.00 | 85.26 | 24,981.24 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024731/0001209191-19-024731-index.htm |
| 2019-05-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,500.00 | 90.70 | 136,043.10 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119030723/0001209191-19-030723-index.htm |
| 2019-06-17 | Jason Douglas Wilson | Chief Financial Officer | Sell | 495.00 | 84.76 | 41,954.12 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119037987/0001209191-19-037987-index.htm |
| 2019-07-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,200.00 | 85.64 | 102,762.84 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119042341/0001209191-19-042341-index.htm |
| 2019-08-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 100.00 | 74.50 | 7,450.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119046280/0001209191-19-046280-index.htm |
| 2018-11-01 | Keith Wayne Ward | Chief Development Officer | Sell | 4,750.00 | 59.48 | 282,530.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/0001209191-18-056805-index.htm |
| 2018-11-07 | Keith Wayne Ward | Chief Development Officer | Sell | 1,053.00 | 68.13 | 71,740.89 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/0001209191-18-057707-index.htm |
| 2019-01-02 | Keith Wayne Ward | Chief Development Officer | Sell | 1,320.00 | 54.58 | 72,045.60 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/0001209191-19-000798-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 100.00 | 104.15 | 10,414.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-03-19 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,100.00 | 95.01 | 104,508.03 | 100.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020743/0001209191-19-020743-index.htm |
| 2019-08-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,772.00 | 73.11 | 129,545.43 | 100.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119046280/0001209191-19-046280-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 1,830.00 | 103.54 | 189,481.68 | 100.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-10-15 | Jason Douglas Wilson | Executive VP of Operations | Sell | 300.00 | 146.61 | 43,983.51 | 10,250.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053134/0001209191-19-053134-index.htm |
| 2018-11-07 | Keith Wayne Ward | Chief Development Officer | Sell | 3,697.00 | 66.64 | 246,368.08 | 1,053.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/0001209191-18-057707-index.htm |
| 2019-10-15 | Jason Douglas Wilson | Executive VP of Operations | Sell | 11,800.00 | 145.55 | 1,717,433.36 | 10,550.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053134/0001209191-19-053134-index.htm |
| 2018-12-11 | CPMG Inc | Director | Buy | 52,809.00 | 60.07 | 3,172,336.97 | 109,408.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2019-01-31 | Keith Wayne Ward | Chief Development Officer | Sell | 1,400.00 | 76.17 | 106,640.66 | 11,370.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/0001209191-19-006341-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 7,019.00 | 99.48 | 698,219.24 | 11,432.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-11-18 | CPMG Inc | Director | Buy | 7,104.00 | 183.00 | 1,300,032.00 | 116,512.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/0000905148-19-001001-index.htm |
| 2019-03-05 | James Edward Bass | Director | Sell | 5,852.00 | 100.29 | 586,919.90 | 11,703.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017820/0001209191-19-017820-index.htm |
| 2019-10-14 | Elaine Castellanos | Principal Accounting Officer | Sell | 3,000.00 | 105.00 | 315,000.00 | 11,933.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053131/0001209191-19-053131-index.htm |
| 2019-10-15 | Elaine Castellanos | Principal Accounting Officer | Sell | 2,000.00 | 160.00 | 320,000.00 | 11,933.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053437/0001209191-19-053437-index.htm |
| 2019-10-18 | Elaine Castellanos | Principal Accounting Officer | Sell | 2,000.00 | 170.00 | 340,000.00 | 11,933.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053681/0001209191-19-053681-index.htm |
| 2019-03-19 | Jason Douglas Wilson | Chief Financial Officer | Sell | 7,249.00 | 94.16 | 682,549.89 | 1,200.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020743/0001209191-19-020743-index.htm |
| 2019-07-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 989.00 | 84.73 | 83,798.07 | 1,200.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119042341/0001209191-19-042341-index.htm |
| 2019-01-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 2,728.00 | 70.94 | 193,523.50 | 1,272.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119003934/0001209191-19-003934-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 400.00 | 207.48 | 82,992.00 | 12,950.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-01-02 | Keith Wayne Ward | Chief Development Officer | Sell | 2,830.00 | 53.71 | 151,999.30 | 1,320.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/0001209191-19-000798-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 400.00 | 206.89 | 82,754.00 | 13,350.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 200.00 | 205.08 | 41,015.00 | 13,750.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-11-18 | CPMG Inc | Director | Buy | 27,322.00 | 183.00 | 4,999,926.00 | 137,962.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/0000905148-19-001001-index.htm |
| 2019-10-15 | Elaine Castellanos | Principal Accounting Officer | Sell | 12,000.00 | 145.52 | 1,746,240.00 | 13,933.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053437/0001209191-19-053437-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 1,480.00 | 204.54 | 302,722.16 | 13,950.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-05-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,600.00 | 89.82 | 143,718.08 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119030723/0001209191-19-030723-index.htm |
| 2019-10-25 | Elaine Castellanos | VP, Chief Accounting Officer | Sell | 2,000.00 | 190.00 | 380,000.00 | 15,146.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119054248/0001209191-19-054248-index.htm |
| 2019-10-28 | Elaine Castellanos | VP, Chief Accounting Officer | Sell | 4,000.00 | 200.00 | 800,000.00 | 15,146.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119054468/0001209191-19-054468-index.htm |
| 2019-12-02 | Elaine Castellanos | VP, Chief Accounting Officer | Sell | 2,000.00 | 194.24 | 388,480.00 | 15,146.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119058681/0001209191-19-058681-index.htm |
| 2020-03-02 | Elaine Castellanos | VP, Chief Accounting Officer | Sell | 2,000.00 | 194.32 | 388,640.00 | 15,146.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919120014386/0001209191-20-014386-index.htm |
| 2020-06-01 | Elaine Castellanos | VP, Chief Accounting Officer | Sell | 2,000.00 | 143.97 | 287,940.00 | 15,146.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919120033270/0001209191-20-033270-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 2,320.00 | 203.60 | 472,342.26 | 15,430.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-04-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,695.00 | 83.52 | 141,574.20 | 1,593.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024731/0001209191-19-024731-index.htm |
| 2019-02-26 | Keith Wayne Ward | Chief Development Officer | Sell | 16,817.00 | 91.00 | 1,530,347.00 | 16,987.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/0001209191-19-014057-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 3,400.00 | 202.51 | 688,534.00 | 17,750.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 8,489.00 | 98.60 | 837,040.02 | 18,451.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-08-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 2,128.00 | 72.25 | 153,739.28 | 1,872.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119046280/0001209191-19-046280-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 4,161.00 | 102.51 | 426,535.79 | 1,930.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-11-20 | WILLIAM ROSE | Director | Sell | 2,000.00 | 215.32 | 430,640.00 | 19,795.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2020-08-14 | Manmeet Singh Soni | COO and CFO | Buy | 2,000.00 | 100.22 | 200,440.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919120046765/0001209191-20-046765-index.htm |
| 2019-06-17 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,357.00 | 83.20 | 112,906.88 | 2,043.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119037987/0001209191-19-037987-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 1,300.00 | 201.65 | 262,145.52 | 21,150.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-03-05 | Elaine Castellanos | Principal Accounting Officer | Sell | 3,588.00 | 102.00 | 365,976.00 | 2,138.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017824/0001209191-19-017824-index.htm |
| 2019-04-08 | Elaine Castellanos | Principal Accounting Officer | Sell | 2,000.00 | 90.17 | 180,340.00 | 2,138.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024119/0001209191-19-024119-index.htm |
| 2019-06-03 | Elaine Castellanos | Principal Accounting Officer | Sell | 2,000.00 | 85.20 | 170,400.00 | 2,138.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119034656/0001209191-19-034656-index.htm |
| 2019-09-06 | Elaine Castellanos | Principal Accounting Officer | Sell | 2,000.00 | 85.00 | 170,000.00 | 2,138.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119049007/0001209191-19-049007-index.htm |
| 2019-11-20 | WILLIAM ROSE | Director | Sell | 2,000.00 | 211.27 | 422,540.00 | 21,795.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2019-07-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,811.00 | 83.93 | 151,995.06 | 2,189.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119042341/0001209191-19-042341-index.htm |
| 2019-12-16 | Jason Douglas Wilson | Executive VP of Operations | Sell | 500.00 | 200.17 | 100,086.40 | 22,450.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119060929/0001209191-19-060929-index.htm |
| 2019-11-20 | WILLIAM ROSE | Director | Sell | 2,000.00 | 210.00 | 420,000.00 | 23,795.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2019-11-20 | WILLIAM ROSE | Director | Sell | 591.00 | 215.89 | 127,590.99 | 25,795.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2018-12-10 | CPMG Inc | Director | Buy | 26,174.00 | 57.93 | 1,516,335.72 | 26,174.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2019-11-19 | WILLIAM ROSE | Director | Sell | 2,000.00 | 210.00 | 420,000.00 | 26,386.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2018-12-10 | CPMG Inc | Director | Buy | 1,078.00 | 58.62 | 63,194.30 | 27,252.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2018-12-12 | CPMG Inc | Director | Buy | 1,418.00 | 59.90 | 84,931.39 | 281,918.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2019-11-18 | CPMG Inc | Director | Buy | 328.00 | 183.00 | 60,024.00 | 282,246.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/0000905148-19-001001-index.htm |
| 2019-11-18 | WILLIAM ROSE | Director | Sell | 600.00 | 200.00 | 120,000.00 | 28,386.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2019-11-18 | WILLIAM ROSE | Director | Sell | 400.00 | 205.10 | 82,040.00 | 28,986.00 | https://www.sec.gov/Archives/edgar/data/1358762/000089924319028597/0000899243-19-028597-index.htm |
| 2019-04-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,300.00 | 84.57 | 109,938.01 | 293.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024731/0001209191-19-024731-index.htm |
| 2018-12-10 | James W JR Traweek | 10% Share Holder | Buy | 26,174.00 | 57.93 | 1,516,335.72 | 2,938,697.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2018-12-10 | R Kent Jr McGaughy | Director | Buy | 26,174.00 | 57.93 | 1,516,335.72 | 2,938,697.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2018-12-10 | James W JR Traweek | 10% Share Holder | Buy | 1,078.00 | 58.62 | 63,194.30 | 2,939,775.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2018-12-10 | R Kent Jr McGaughy | Director | Buy | 1,078.00 | 58.62 | 63,194.30 | 2,939,775.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2018-12-10 | James W JR Traweek | 10% Share Holder | Buy | 29,347.00 | 59.53 | 1,747,035.71 | 2,969,122.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2018-12-10 | R Kent Jr McGaughy | Director | Buy | 29,347.00 | 59.53 | 1,747,035.71 | 2,969,122.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2020-08-14 | Manmeet Singh Soni | COO and CFO | Buy | 1,000.00 | 100.19 | 100,190.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919120046765/0001209191-20-046765-index.htm |
| 2018-12-11 | James W JR Traweek | 10% Share Holder | Buy | 52,809.00 | 60.07 | 3,172,336.97 | 3,021,931.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2018-12-11 | R Kent Jr McGaughy | Director | Buy | 52,809.00 | 60.07 | 3,172,336.97 | 3,021,931.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2018-12-12 | James W JR Traweek | 10% Share Holder | Buy | 1,418.00 | 59.90 | 84,931.39 | 3,023,349.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000922/0000905148-18-000922-index.htm |
| 2018-12-12 | R Kent Jr McGaughy | Director | Buy | 1,418.00 | 59.90 | 84,931.39 | 3,023,349.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000921/0000905148-18-000921-index.htm |
| 2019-11-18 | James W JR Traweek | 10% Share Holder | Buy | 40,218.00 | 183.00 | 7,359,894.00 | 3,063,567.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001003/0000905148-19-001003-index.htm |
| 2019-11-18 | R Kent Jr McGaughy | Director | Buy | 40,218.00 | 183.00 | 7,359,894.00 | 3,063,567.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001002/0000905148-19-001002-index.htm |
| 2019-05-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 900.00 | 88.74 | 79,869.96 | 3,100.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119030723/0001209191-19-030723-index.htm |
| 2019-04-15 | Jason Douglas Wilson | Chief Financial Officer | Sell | 712.00 | 82.54 | 58,768.20 | 3,288.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119024731/0001209191-19-024731-index.htm |
| 2019-06-17 | Jason Douglas Wilson | Chief Financial Officer | Sell | 600.00 | 82.08 | 49,245.78 | 3,400.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119037987/0001209191-19-037987-index.htm |
| 2019-06-17 | Jason Douglas Wilson | Chief Financial Officer | Sell | 1,548.00 | 84.02 | 130,069.77 | 495.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119037987/0001209191-19-037987-index.htm |
| 2018-11-16 | James Edward Bass | Director | Buy | 1,679.00 | 59.33 | 99,615.07 | 53,222.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919118059094/0001209191-18-059094-index.htm |
| 2018-12-20 | James Edward Bass | Director | Buy | 888.00 | 52.12 | 46,286.56 | 54,110.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919118063808/0001209191-18-063808-index.htm |
| 2019-11-18 | CPMG Inc | Director | Buy | 5,464.00 | 183.00 | 999,912.00 | 5,464.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/0000905148-19-001001-index.htm |
| 2018-12-10 | CPMG Inc | Director | Buy | 29,347.00 | 59.53 | 1,747,035.71 | 56,599.00 | https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/0000905148-18-000920-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 300.00 | 101.69 | 30,507.51 | 6,091.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-03-05 | MICHAEL D WORTLEY | Chief Legal Officer | Sell | 5,041.00 | 100.43 | 506,242.43 | 6,391.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119017840/0001209191-19-017840-index.htm |
| 2019-10-14 | Jason Douglas Wilson | Executive VP of Operations | Sell | 15,000.00 | 100.00 | 1,500,000.00 | 7,350.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053134/0001209191-19-053134-index.htm |
| 2019-10-15 | Jason Douglas Wilson | Executive VP of Operations | Sell | 2,900.00 | 148.46 | 430,539.51 | 7,350.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053134/0001209191-19-053134-index.htm |
| 2019-10-17 | Jason Douglas Wilson | Executive VP of Operations | Sell | 10,000.00 | 170.00 | 1,700,000.00 | 7,350.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119053686/0001209191-19-053686-index.htm |
| 2019-03-19 | Jason Douglas Wilson | Chief Financial Officer | Sell | 19,947.00 | 93.18 | 1,858,581.67 | 8,449.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119020743/0001209191-19-020743-index.htm |
| 2019-01-31 | Keith Wayne Ward | Chief Development Officer | Sell | 2,750.00 | 76.97 | 211,661.45 | 8,620.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/0001209191-19-006341-index.htm |
| 2019-02-25 | Keith Wayne Ward | Chief Development Officer | Sell | 15,183.00 | 91.00 | 1,381,653.00 | 8,620.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/0001209191-19-014057-index.htm |
| 2019-02-26 | Keith Wayne Ward | Chief Development Officer | Sell | 8,367.00 | 91.62 | 766,584.54 | 8,620.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/0001209191-19-014057-index.htm |
| 2019-09-27 | James Warren Huff | Chief Executive Officer | Sell | 63,000.00 | 86.61 | 5,456,115.00 | 94,157.00 | https://www.sec.gov/Archives/edgar/data/1358762/000120919119051083/0001209191-19-051083-index.htm |